Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Pharma
WuXi Biologics stays the course with positive 2024 outlook
Amid a national-security-related reckoning in the U.S., Chinese contract manufacturer WuXi Biologics is accentuating the positive.
Fraiser Kansteiner
Mar 27, 2024 1:44pm
AZ plans separate drug supply chains for US and China, CEO says
Mar 27, 2024 12:27pm
Sanofi calls on 3 drugmakers to market its meds overseas
Mar 27, 2024 9:57am
Brazil taps nonprofit to slash cell therapy production costs
Mar 26, 2024 8:44am
Novo Nordisk, Actylis ink pact to supply antiseptic in Europe
Mar 25, 2024 10:15am
Merck KGaA's MilliporeSigma makes €300M pledge at new Korea site
Mar 21, 2024 1:22pm